ROS-induced imbalance of the miR-34a-5p/SIRT1/p53 axis triggers chronic chondrocyte injury and inflammation.

Autor:	Zhou M; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China.; Department of Orthopedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Institute for Tissue Engineering and Regenerative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Liu B; Department of Orthopedics, Shenzhen People's Hospital, Shenzhen, 518020, Guangdong, China.; The Second Clinical Medical College, Jinan University, Shenzhen, 518020, Guangdong, China.; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, 518020, Guangdong, China., Ye HM; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Hou JN; Department of General Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China., Huang YC; Department of Orthopedic Surgery, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, 523000, China., Zhang P; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Gao L; Center for Clinical Medicine, Huatuo Institute of Medical Innovation (HTIMI), Berlin, Germany., Qin HT; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Yang YF; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Zeng H; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Kang B; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Yu F; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Wang DL; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China., Lei M; Department of Bone and Joint Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.; National and Local Joint Engineering Research Center for Orthopedic Biomaterials, Shenzhen, 518036, Guangdong, China.; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen, 518036, Guangdong, China.
Jazyk:	angličtina
Zdroj:	Heliyon [Heliyon] 2024 May 22; Vol. 10 (11), pp. e31654. Date of Electronic Publication: 2024 May 22 (Print Publication: 2024).
DOI:	10.1016/j.heliyon.2024.e31654
Abstrakt:	Osteoarthritis is a chronic degenerative disease based on the degeneration and loss of articular cartilage. Inflammation and aging play an important role in the destruction of the extracellular matrix, in which microRNA (miRNA) is a key point, such as miRNA-34a-5p. Upregulation of miRNA-34a-5p was previously reported in a rat OA model, and its inhibition significantly suppressed interleukin (IL)-1β-induced apoptosis in rat chondrocytes. However, Oxidative stress caused by reactive oxygen species (ROS) can exacerbate the progression of miRNA regulated OA by mediating inflammatory processes. Thus, oxidative stress effects induced via tert -butyl hydroperoxide (tBHP) in human chondrocytes were assessed in the current research by evaluating mitochondrial ROS production, mitochondrial cyclooxygenase (COX) activity, and cell apoptosis. We also analyzed the activities of antioxidant enzymes including glutathione peroxidase (GSH-Px), catalase (CAT), and superoxide dismutase (SOD). Additionally, inflammatory factors, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-8, and IL-24, which contribute to OA development, were detected by enzyme-linked immunosorbent assay (ELISA). The results of this study indicated that miR-34a-5p/silent information regulator 1 (SIRT1)/p53 axis was involved in the ROS-induced injury of human chondrocytes. Moreover, dual-luciferase assay revealed that SIRT1 expression was directly regulated by miR-34a-5p, indicating the presence of a positive feedback loop in the miR-34a-5p/SIRT1/p53 axis that plays an important role in cell survival. However, ROS disrupted the miR-34a-5p/SIRT1/p53 axis, leading to the development of OA, and articular injection of SIRT1 agonist, SRT1720, in a rat model of OA effectively ameliorated OA progression in a dose-dependent manner. Our study confirms that miRNA-34a-5p could participate in oxidative stress responses caused by ROS and further regulate the inflammatory process via the SIRT1/p53 signaling axis, ultimately affecting the onset of OA, thus providing a new treatment strategy for clinical treatment of OA. Competing Interests: The data results of this study can be obtained from the corresponding author according to reasonable requirements. There is no conflict of interest between the authors. (© 2024 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu